Federal
Register Notices > Importers
>
Cambrex Charles City, Inc.
FR Doc E7-2992 [Federal Register: February 22, 2007 (Volume 72, Number 35)]
[Notices] [Page 8017] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22fe07-79]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a registration
under this Section to a bulk manufacturer of a controlled substance in
schedule I or II and prior to issuing a regulation under 21
U.S.C. Sec. 952(a)(2)(B) authorizing the importation of such a substance,
provide manufacturers holding registrations for the bulk manufacture of the
substance an opportunity for a hearing.
Therefore, in accordance with 21
CFR 1301.34(a), this is notice that on November 27, 2005, Cambrex Charles
City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered as an
importer of Phenylacetone (8501), a basic class of controlled substance listed
in schedule II.
The company plans to import Phenylacetone for use as a precursor in the
manufacture of amphetamines only.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic class of controlled substance may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such written comments or objections being sent via regular mail should
be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration, Washington, DC 20537,
Attention: DEA Federal Register Representative/ODL; or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than March 26, 2007.
This procedure is to be conducted simultaneously with and independent of
the procedures described in 21
CFR Sec. 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice
published in the Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substance listed in schedule I or II are, and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for such
registration pursuant to 21
U.S.C. 958(a), 21
U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: February 14, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-2992 Filed 2-21-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|